For patients aged ≥60 years, there were no signs of a decreasing trend.
← all excerpts
The prevalence of polypharmacy increases with age among patients with inflammatory bowel disease: A nationwide cohort study.
1
—
—
For patients aged ≥60 years, there were no signs of a decreasing trend.